Evidence map›Paper›PMID 40508207›Full record

ArticleInternational journal of molecular sciences2025

Dinara Baiskhanova, Maike Menzel, Claudia Geismann, Christoph Röcken, Eric Beitz, Susanne Sebens, Anna Trauzold, Heiner Schäfer

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dinara BaiskhanovaInstitute of Experimental Cancer Research, UKSH Campus Kiel, Arnold-Heller-Str. 3, Bldg. U30, 24105 Kiel, Germany.ORCID 0009-0003-6610-4726
Maike MenzelDepartment of Pharmacy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.
Claudia GeismannDepartment of Otorhinolaryngology, Carl-von-Ossietzky University Oldenburg, Ammerländer Heerstraße 114-118, 26129 Oldenburg, Germany.ORCID 0000-0003-0640-9256
Christoph RöckenDepartment of Pathology, Christian-Albrechts-University Kiel, Arnold-Heller-Str. 3, Bldg. U33, 24105 Kiel, Germany.ORCID 0000-0002-6989-8002
Eric BeitzDepartment of Pharmacy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.ORCID 0000-0001-5912-6626
Susanne SebensTriBanK, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, Bldg. U30, 24105 Kiel, Germany.ORCID 0000-0001-6582-0083
Anna TrauzoldInstitute of Experimental Cancer Research, UKSH Campus Kiel, Arnold-Heller-Str. 3, Bldg. U30, 24105 Kiel, Germany.ORCID 0000-0003-4697-556X
Heiner SchäferInstitute of Experimental Cancer Research, UKSH Campus Kiel, Arnold-Heller-Str. 3, Bldg. U30, 24105 Kiel, Germany.ORCID 0000-0001-6936-9090

Funding

DAAD 91832744German Research Society DFG 677/15-1
6 · The paper itself

Abstract

Tumor cell heterogeneity, e.g., in stroma-rich pancreatic ductal adenocarcinoma (PDAC), includes a differential metabolism of lactate. While being secreted as waste product by most cancer cells characterized by the glycolytic Warburg metabolism, it is utilized by a subset of highly malignant cancer cells running the reverse Warburg metabolism. Key drivers of lactate transport are the carrier proteins SLC16A1 (import/export) and SLC16A3 (export). Expression and function of both carriers are controlled by the chaperone Basigin (BSG), which itself is functionally controlled by the transmembrane protease serine 11B (TMPRSS11B). In this study we explored the impact of TMPRSS11B on the phenotype of PDAC cells under reverse Warburg conditions. Amongst a panel of PDAC cell lines, Panc1 and BxPc3 cells were identified to express TMPRSS11B at a high level, whilst other cell lines such as T3M4 did not. ShRNA-mediated TMPRSS11B knock-down in Panc1 and BxPc3 cells enhanced lactate import through SLC16A1, as shown by GFP/iLACCO1 lactate uptake assay, whereas TMPRSS1B overexpression in T3M4 dampened SLC16A1-driven lactate uptake. Moreover, knock-down and overexpression of TMPRSS11B differentially impacted proliferation and chemoresistance under reverse Warburg conditions in Panc1 or BxPc3 and T3M4 cells, respectively, as well as their stemness properties indicated by altered colony formation rates and expression of the stem cell markers Nanog, Sox2, KLF4 and Oct4. These effects of TMPRSS11B depended on both SLC16A1 and BSG as shown by gene silencing. Immunohistochemical analysis revealed a reciprocal expression of TMPRSS11B and BSG together with SLC16A1 in some areas of tumor tissues from PDAC patients. Those regions exhibiting low or no TMPRSS11B expression but concomitant high expression of SLC16A1 and BSG revealed greater amounts of KLF4. In contrast, other tumor areas exhibiting high expression of TMPRSS11B together with BSG and SLC16A1 were largely negative for KLF4 expression. Thus, the differential expression of TMPRSS11B adds to metabolic heterogeneity in PDAC and its absence supports the reverse Warburg metabolism in PDAC cells by the enhancement of BSG-supported lactate uptake through SLC16A1 and subsequent phenotype alterations towards greater stemness.

Indexed as

Carcinoma, Pancreatic DuctalLactic AcidMembrane ProteinsMonocarboxylic Acid TransportersPancreatic NeoplasmsSymportersBasiginBiological TransportCell Line, TumorGene Expression Regulation, NeoplasticHumansKruppel-Like Factor 4Monocarboxylate Transport Protein 1PhenotypeBasiginBSG protein, humanKLF4 protein, humanKruppel-Like Factor 4Lactic AcidMembrane ProteinsMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersSymporterscarcinogenesischaperoneproteolysisreverse Warburg metabolism

Identifiers

PMID40508207
PMCPMC12155430

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.